Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Malkoff v. Sequenom, Inc. et al
Case Number:
3:16-cv-02054
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Cooley LLP
- Faruqi & Faruqi
- Grant & Eisenhofer
- Greene & Roberts
- Hogan Lovells
- Johnson Fistel
- Jones Day
- Law Offices of Ronald A. Marron
- Levi & Korsinsky
- Robbins Geller
- Schneider Wallace
- WeissLaw LLP
Companies
Sectors & Industries:
-
July 28, 2023
Sequenom Beats Suit Over $371M Sale To LabCorp, For Now
A California federal judge on Thursday tossed a 7-year-old investor suit against prenatal diagnostic company Sequenom Inc., saying the investors show no facts that the board misled investors by approving LabCorp's $371 million takeover at $2.40 per share, but ruled the plaintiffs can amend the suit and try again.
-
June 07, 2017
Robbins Geller To Lead Investor Suit Over Sequenom Deal
A California federal judge has appointed Robbins Geller Rudman & Dowd LLP as lead counsel in an investor suit against prenatal diagnostic company Sequenom Inc., saying on Tuesday that none of the other investors have challenged the presumptive lead plaintiff status of the law firm's client.
-
August 16, 2016
Sequenom Investors Sue To Block LabCorp Takeover Bid
Sequenom Inc. investors hit the prenatal diagnostics company with a putative securities class action in California federal court Monday, alleging it misled investors about Laboratory Corp. of America's $371 million takeover bid and seeking to block the deal.